FCMV
Foresite Capital Management V Portfolio holdings
AUM
$80.7M
1-Year Return
24.46%
This Quarter Return
+3.72%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
–
10 Year Return
–
AUM
$80.7M
AUM Growth
-$6.89M
(-7.9%)
Cap. Flow
+$3.77M
Cap. Flow
% of AUM
4.67%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
CG Oncology
CGON
|
$3.77M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 83.13% |
| 2 | Consumer Staples | 16.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CG Oncology
CGON
$2.52B
| $26.1M | 32.34% |
1,004,050
+145,000
| +17% | +$3.77M |
|
|
ALMS
2
Alumis Inc. Common Stock
ALMS
$469M
| $17.3M | 21.48% |
5,779,348
| – | – |
|
3
Disc Medicine
IRON
$2.11B
| $15.8M | 19.62% |
299,069
| – | – |
|
4
Hims & Hers Health
HIMS
$10.9B
| $13.6M | 16.87% |
273,151
| – | – |
|
|
MAZE
5
Maze Therapeutics, Inc. Common Stock
MAZE
$696M
| $4.24M | 5.25% |
345,191
| – | – |
|
6
Lyell Immunopharma
LYEL
$233M
| $3.59M | 4.45% |
406,652
| – | – |
|